SB 1211 — pharmacists; prescribing; naloxone; reporting

SenateHouse Engrossed Senate Bill pharmacists;

reporting State of Arizona Senate Fifty-sixth Legislature Second Regular Session CHAPTER 232 SENATE BILL 1211 AN ACT AMENDING SECTIONS 32-1907, 32-1968, 32-1979 AND 36-2608, ARIZONA REVISED STATUTES;

Section 32-1907, Arizona Revised Statutes, is amended to read:

32-1907.

Arizona state board of pharmacy fund A.

Except as provided in section 32-1939, the executive director shall receive and receipt for all fees and other monies provided for in this chapter and shall deposit, pursuant to sections 35-146 and 35-147, ten percent of such monies in the state general fund and ninety percent in the Arizona state board of pharmacy fund.

All monies derived from civil penalties collected pursuant to this chapter shall be deposited, pursuant to sections 35-146 and 35-147, in the state general fund.

B.

Except as provided in subsection C of this section, monies deposited in the Arizona state board of pharmacy fund shall be ARE subject to section 35-143.01.

C.

From monies deposited in the Arizona state board of pharmacy fund pursuant to subsection A of this section, the executive director may transfer up to five hundred thousand dollars $500,000 annually to the controlled substances prescription monitoring program fund established by section 36-2605 for expenses related to the controlled substances prescription monitoring program as required by title 36, chapter 28.

D.

From monies deposited in the Arizona state board of pharmacy fund pursuant to subsection A of this section, the executive director may transfer up to one million dollars $1,OOO,OOO annually to EACH the Arizona poison and drug information center AND A POISON AND DRUG INFORMATION CENTER THAT SERVES MARICOPA COUNTY for the purposes specified in section 36-1161 to supplement, and not supplant, any state general fund appropriation for those purposes.

Sec.

2.

5.- 1 - S.B.

1211 5.

Any drug dispensed in accordance with subsection A of this section is exempt from the requirements of section 32-1967, except section 32-1967, subsection A, paragraphs 1, 10 and 11 and the packaging -requirements 1of -section S.B.32-1967, subsection A, paragraphs 7 and 8, if the drug container bears a label containing the name and address of the dispenser, the serial number, the date of dispensing, the name of the prescriber, the name of the patient, or, if an animal, the name of the owner of the animal and the species of the animal, directions for use and cautionary statements, if any, contained in the order.

1211 requirements of section 32-1967, subsection A, paragraphs 7 and 8, if the drug container bears a label containing the name and address of the dispenser, the serial number, the date of dispensing, the name of the prescriber, the name of the patient, or, if an animal, the name of the owner of the animal and the species of the animal, directions for use and cautionary statements, if any, contained in the order.

G.- 2 - S.B.

1211 G.

2.3.

-2. 2 - S.B.

1211 2.

3.4.

If a medical practitioner dispenses a controlled substance listed in section 36-2513, 36-2514, 36-2515 or 36-2516 or the rules adopted pursuant to chapter 27, article 2 of this title, or if a prescription- for3 a- controlledS.B. substance listed in any of those sections or naloxone hydrochloride or any other opioid antagonist that is approved by the United States food and drug administration is dispensed by a pharmacy in this state, a health care facility in this state for outpatient use or a board-permitted nonresident pharmacy for delivery to a person residing in this state, the medical practitioner, health care facility or pharmacy must report the following information as applicable and as prescribed by the board by rule:

1211 prescription for a controlled substance listed in any of those sections or naloxone hydrochloride or any other opioid antagonist that is approved by the United States food and drug administration is dispensed by a pharmacy in this state, a health care facility in this state for outpatient use or a board-permitted nonresident pharmacy for delivery to a person residing in this state, the medical practitioner, health care facility or pharmacy must report the following information as applicable and as prescribed by the board by rule:

-C. 3 - S.B.

1211 C.

2.- 4 - S.B.

1211 2.

4.5.

-APPROVED 4BY -THE GOVERNOR JUNE 21, 2024.

FILED IN THE OFFICE OF THE SECRETARY OF STATE JUNE 21, 2024.

- 5 -